Topicin Global Markets

Rhythm Pharmaceuticals

Latest news, explainers and analysis on Rhythm Pharmaceuticals. Tracking 1 stories on Arth Vani.

1 stories tracked

Connected in the graph

Pharmaceuticals19

Latest on Rhythm Pharmaceuticals

Global Markets

Druckenmiller Bets on Rhythm Pharma for Rare Obesity Untouched by Eli Lilly, Novo Nordisk

Billionaire investor Stanley Druckenmiller is reportedly investing in Rhythm Pharmaceuticals, a company focused on treating rare genetic forms of obesity. This move stands apart from the broader market trend, as Rhythm's treatments target conditions not addressed by popular weight-loss drugs from pharmaceutical giants like Eli Lilly and Novo Nordisk. Druckenmiller's strategy highlights a focus on specialized, unmet medical needs within the burgeoning obesity treatment sector.

3h ago·2 min readListen

Global Markets products

Compare & act on the right product for this topic

Smart picks

Nippon India Small Cap Fund

Nippon India Mutual Fund · Small Cap

17.4%

3Y CAGR

Bharat Mobility IPO

Mainboard · Auto

+20.5%

GMP

View IPO

Parag Parikh Flexi Cap Fund

PPFAS Mutual Fund · Flexi Cap

14.4%

3Y CAGR

GreenVolt Energy IPO

Mainboard · Renewables

+13.8%

GMP

View IPO

Mirae Asset ELSS Tax Saver Fund

Mirae Asset Mutual Fund · ELSS

14.2%

3Y CAGR

HDFC Balanced Advantage Fund

HDFC Mutual Fund · Hybrid

13.2%

3Y CAGR

Compare & decide

All comparisons

Read comparison

Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.

Explore all entities in the Knowledge Graph